Not taking mRNA vaccines? One more angmoh vaccine coming your way from big pharma. Sponsored by USA operation warp speed grant one

[ginfreely]

No, ang mo will not be involved much most likely. as mentioned if you know science you will realise the vaccine produced the technology is totally identical to the one GSK is producing. GSK is mass hiring now, so most of us suspect this current mass hiring is because of this collaboration. So high likely they will be using existing GSK plant to train the scientist now, once the plant is ready, it will be up and running immediately as everyone is trained. it make more sense to second existing professional from GSK over.

No according to here the vaccine is combo of sanofi flu vaccine recombinant DNA technology and GSK h1n1 vaccine technology so should not be totally identical to the one GSK is producing.

https://www.fiercepharma.com/pharma...ation-warp-speed-funding-for-covid-19-vaccine

The vaccine is developed with Sanofi’s recombinant DNA technology that’s used in the French pharma’s FDA-approved flu shot Flublok, plus GSK’s adjuvant AS03, which was used in the company’s H1N1 pandemic flu vaccine Pandemrix. Both are proven technologies, compared with some other projects Operation Warp Speed’s backing.

 

[ginfreely]

https://en.wikipedia.org/wiki/AS03

AS03 (for "Adjuvant System 03") is the trade name for a squalene-based immunologic adjuvant used in various vaccine products by GlaxoSmithKline (GSK). It is used, for example, in GSK's A/H1N1 pandemic flu vaccine Pandemrix. It is also in Arepannix and the Q-pan for H5N1 influenza.[1]

A dose of AS03 adjuvant contains[2]

• 10.69 mg squalene
• 11.86 mg DL-α-tocopherol
• 4.86 mg polysorbate 80

In the 2009 influenza pandemic, vaccines containing AS03 delivered a stronger immunogene response against pandemic H1N1 influenza than non-adjuvanted vaccines, despite their containing lower levels of viral antigen.[3]

 

[ginfreely]

https://www.precisionvaccinations.c...rm-produce-recombinant-2019-novel-coronavirus

Sanofi’s egg-free, recombinant DNA technology is reported to produce an exact genetic match to proteins of the virus.

The protein’s DNA will be combined with DNA from a virus harmless to humans and used to rapidly produce large quantities of antigen which stimulate the immune system to protect against the virus.

The antigens will be separated and collected from these cells and purified to create working stocks of vaccine for advanced development.

 

[ginfreely]

https://www.precisionvaccinations.c...rm-produce-recombinant-2019-novel-coronavirus

BARDA has worked with Sanofi since 2004 and in 2009 began collaborating with Protein Sciences of Meridian, Connecticut, which Sanofi purchased in 2017, to develop a recombinant technology with the flexibility to make millions of doses of vaccine quickly in an influenza pandemic.

In 2016, BARDA added this vaccine to the U.S. National Pre-pandemic Influenza Vaccine Stockpile.

 

[ginfreely]

No, ang mo will not be involved much most likely. as mentioned if you know science you will realise the vaccine produced the technology is totally identical to the one GSK is producing. GSK is mass hiring now, so most of us suspect this current mass hiring is because of this collaboration. So high likely they will be using existing GSK plant to train the scientist now, once the plant is ready, it will be up and running immediately as everyone is trained. it make more sense to second existing professional from GSK over.

Wow GSK got two plants In Tuas and Jurong. Very good company indeed.

https://www.edb.gov.sg/en/our-industries/company-highlights/gsk.html

GSK has two other plants in Singapore. One is a S$510 million, primary vaccine manufacturing site in Tuas, which was the first of its kind outside Belgium when it was opened in June 2009. Another facility, located in Jurong, manufactures active pharmaceutical ingredients used in a variety of GSK prescription medicines. The latter, with its award-winning sustainable processes and green technologies, is one of the world’s most advanced manufacturing facilities piloting new processes that will change the way medicines are made at GSK.

 

[ginfreely]

It depends whether you want to take the risk of being seriously ill from covid. For me i will not.

For me with lung scarring and lung nodules, i will take zero risk of being seriously ill from covid.

 

[vamjok]

No according to here the vaccine is combo of sanofi flu vaccine recombinant DNA technology and GSK h1n1 vaccine technology so should not be totally identical to the one GSK is producing.

https://www.fiercepharma.com/pharma...ation-warp-speed-funding-for-covid-19-vaccine

The vaccine is developed with Sanofi’s recombinant DNA technology that’s used in the French pharma’s FDA-approved flu shot Flublok, plus GSK’s adjuvant AS03, which was used in the company’s H1N1 pandemic flu vaccine Pandemrix. Both are proven technologies, compared with some other projects Operation Warp Speed’s backing.

if you really understand what you are typing...then go look at what Tuas is producing. you realise its what we chinese call 换汤不换药. its totally identical technology used on different disease. but this is a very smart idea actually, what they produced should be after re-attempt phase 2 seems very promising after adjusting the antigen and adjuvant concentration.